Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

46.27 +0.26 (+0.57%)
Streaming Delayed Price Updated: 12:31 PM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Sanofi - American Depositary Shares

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
36 37 Next >
News headline image
Alphabet, Apple And 3 Stocks To Watch Heading Into Friday ↗
With Nasdaq stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
News headline image
Fear & Greed Index Remains In 'Greed' Zone As Nasdaq Record Sharp Gains For Fourth Straight Week ↗
The CNN Money Fear and Greed index showed some decline in overall sentiment among US investors. US stocks closed mostly higher on Thursday, with the tech-laden Nasdaq index leading the rally. Investors... 
Via Benzinga
News headline image
Earnings Outlook For Sanofi ↗
 
Via Benzinga
News headline image
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More ↗
The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new... 
Via Benzinga
News headline image
Hopeful Golden Cross Forms On Sanofi's Chart ↗
 
Via Benzinga
News headline image
What Does Sanofi's Debt Look Like? ↗
Over the past three months, shares of Sanofi Inc. (NASDAQ:SNY) increased by 20.92%. Before having a look at the importance of debt, let's look at how much debt Sanofi has. 
Via Benzinga
News headline image
Sanofi Forecasts Foreign Exchange, Record Flu Vaccine Sales To Boost Q4 Earnings ↗
 
Via Benzinga
News headline image
Sanofi Layoffs 2023: What to Know About the Latest SNY Job Cuts ↗
One French pharmaceutical producer is implementing job cuts. Here's what investors need to know about the Sanofi layoffs. 
Via InvestorPlace
News headline image
Sanofi Might Pull Down Shutters For Two Vaccine Plants In India ↗
After Sanofi SA (NASDAQ: SNY) failed to secure a UNICEF contract, the company is weighing closing operations at two of its vaccine-making facilities in Hyderabad, India, and plans to let go of all... 
Via Benzinga
News headline image
Europe Approves Regeneron-Sanofi's Dupixent For Expanded Use In Eosinophilic Esophagitis ↗
 
Via Benzinga
News headline image
Could This Vaccine Become Sanofi's Latest Blockbuster? ↗
This vaccine candidate could be approved in newborns and infants later this year. 
Via The Motley Fool
News headline image
7 Blue-Chip Stocks to Buy as a New Bull Market Emerges ↗
Many blue-chip stocks look like a bargain right now, and these seven companies are certainly no exception. 
Via InvestorPlace
News headline image
Wall Street Thinks These 2 Blazing Healthcare Stocks Could Have 21% to 30% Upside in 2023 ↗
It's difficult to imagine a future where healthcare isn't in high demand. 
Via The Motley Fool
News headline image
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch ↗
With a full week of earnings behind us, it’s time to take stock of the fourth-quarter reporting season so far. Overall, the news flow has been mixed, although tech earnings have grossly disappointed. 
Via Benzinga
News headline image
Pharmaceutical Stocks Pfizer, GSK, Moderna Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market ↗
After years of lab failures, the companies could crack open a multibillion-dollar market. 
Via Investor's Business Daily
News headline image
The Viral “Tripledemic” Opportunity ↗
Between Covid, the flu, and RSV, investors in over-the-counter consumer pharmaceutical companies might be wondering if now is a logical time to up their holdings in the companies that make cold and flu... 
Via Talk Markets
News headline image
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot ↗
Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand. 
Via Benzinga
News headline image
Sanofi Opts To Terminate Rare Disease Program With Regulus Therapeutics ↗
 
Via Benzinga
News headline image
What This Drug News Could Mean for Sanofi Shareholders ↗
This star drug for Sanofi is one step closer to approval in the European Union for another chronic inflammatory disease. 
Via The Motley Fool
News headline image
5 Top Pharma Stocks of 2022 to Buy for the Long Haul ↗
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks. 
Via InvestorPlace
News headline image
FDA Permits Pharmacies To Distribute Abortion Pills, Tesla's Aggressive Discounting May Have Hit Gross Margins, Goldman Sachs Bullish On M&A Activity In Late 2023: Top Stories Today ↗
Reuters Goldman Sachs Bullish On M&A Deals Activity Picking Up In Late 2023 
Via Benzinga
News headline image
Could This Drug News Give a Lift to Eli Lilly Stock? ↗
In November, Eli Lilly received positive news from the U.S. Food and Drug Administration. 
Via The Motley Fool
News headline image
3 Medical Dividend Stocks That Hit the Sweet Spot ↗
These three offer high dividend yields and consistent revenue growth. 
Via The Motley Fool
News headline image
After Five Years Of Collaboration, Sanofi & Innate Pharma Expand Oncology Pact With Additional Programs ↗
 
Via Benzinga
News headline image
Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review ↗
Moderna spiked on a cancer vaccine while Tesla continued to dive. 
Via Investor's Business Daily
News headline image
2 Best Biotech Stocks to Buy Right Now ↗
Demand for medicines and vaccines has nowhere to go but up over the long run. 
Via The Motley Fool
News headline image
Regeneron-Sanofi's Dupixent Wins European Approval For Prurigo Nodularis ↗
 
Via Benzinga
News headline image
These Biotech Stocks Are the Nasdaq's Big Wednesday Winners ↗
Business wins are shining the spotlight on these two companies. 
Via The Motley Fool
News headline image
Why Is Kymera Therapeutics (KYMR) Stock Up 20% Today? ↗
KYMR stock traders are bidding up the share price today as Kymera Therapeutics teams up to take a skin condition treatment to the next phase. 
Via InvestorPlace
News headline image
Kymera Therapeutics Stock Jumps After Positive Data From Atopic Dermatitis Trial ↗
 
Via Benzinga
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
36 37 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.